Advanced search
Publication Cover
Postgraduate Medicine Volume 133, 2021 - Issue 5
Submit an article Journal homepage
590
Views
11
CrossRef citations to date
0
Altmetric
Clinical focus: Pulmonary and Respiratory Conditions - Case Report

Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVİD-19 Patient: A Case Report and Literature Review

Narimana Imanova YaghjiFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Ondokuz Mayıs University, Samsun, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8842-901XView further author information
ORCID Icon,
Elif Kilic KanFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Ondokuz Mayıs University, Samsun, TurkeyORCID Iconhttps://orcid.org/0000-0002-9047-3121View further author information
ORCID Icon,
Songul AkcanFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Ondokuz Mayıs University, Samsun, TurkeyView further author information
,
Ramis ColakFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Ondokuz Mayıs University, Samsun, TurkeyView further author information
&
Aysegul AtmacaFaculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Ondokuz Mayıs University, Samsun, TurkeyView further author information
Pages 548-551 | Received 10 Feb 2021, Accepted 10 Feb 2021, Published online: 26 Feb 2021

References

  • Page F. Treatment of lupus erythematosus with mepacrine. Lancet. 1951;258(6687):755–758.
  • Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020 Mar;16(3):155–166. Epub 2020 Feb 7. PMID: 32034323.
  • Ducharme J, Farinotti R. Clinical Pharmacokinetics and Metabolism of Chloroquine. Clin Pharmacokinet. 1996;31(4):257–274.
  • Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–1460.
  • Tönnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy - a review of the literature. Immunopharmacol Immunotoxicol. 2013;35(3):434–442.
  • Penn SK, Kao AH, Schott LL, et al. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 2010;37(6):1136–1142.
  • Chakravarti HN, Nag A. Efficacy and safety of hydroxychloroquine as add-on therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs. J Endocrinol Invest. 2020 Jun 27:1–12. DOI:10.1007/s40618-020-01330-5. Epub ahead of print. PMID: 32594451; PMCID: PMC7320244.
  • Infante M, Ricordi C, Alejandro R, et al. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Rev Anti Infect Ther. 2020 Aug 16:1–12. DOI:10.1080/14787210.2020.1799785. Epub ahead of print. PMID: 32693652; PMCID: PMC7441799.
  • https://covid19.saglik.gov.tr/Eklenti/39061/0/covid-19rehberieriskinhastatedavisipdf.pdf
  • Wallace D. The history of antimalarials. Lupus. 1996;5(1_suppl):2–3.
  • Ben-Zvi I, Kivity S, Langevitz P, et al. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012;42(2):145–153.
  • Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2(1):69.
  • https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  • Devaux CA, Rolain JM, Colson P, et al. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;55(5):105938.
  • Moore BR, Page-Sharp M, Stoney JR, et al. Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrob Agents Chemother. 2011;55(8):3899–3907.
  • Al-Bari MAA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015;70(6):1608–1621.
  • Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin. 2014;30(7):1257–1266.
  • Infante M, Ricordi C, Fabbri A. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risks and benefits at the time of COVID-19 pandemic. J Diabetes. 2020 Sep;12(9):659–667. Epub 2020 Jun 11. PMID: 32401405; PMCID: PMC7272905.
  • Wondafrash DZ, Desalegn TZ, Yimer EM, et al. Potential effect of hydroxychloroquine in diabetes mellitus: a systematic review on preclinical and clinical trial studies. J Diabetes Res. 2020;2020:5214751.
  • Cansu DÜ, Korkmaz C. Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA. Rheumatology. 2008;47(3):378–379.
  • Unübol M, Ayhan M, Guney E. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis. J Clin Rheumatol. 2011;17(1):46–47.
  • Winter EM, Schrander-van der Meer A, Eustatia-Rutten C, et al. Hydroxychloroquine as a glucose lowering drug. BMJ Case Rep. 2011;2011:bcr0620114393.
  • El-Solia A, Al-Otaibi K, Ai-Hwiesh AK. Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis. BMJ Case Rep. 2018;2018:bcr2017223639.
  • Dai Y, Lin G, Shi D. Hypoglycemia induced by hydroxychloroquine sulfate in a patient treated for connective tissue disease without diabetes mellitus. Clin Ther. 2020;42(5):940–945.
  • Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:e201834.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.